OncoMatch

OncoMatch/Clinical Trials/NCT07139990

Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)

Is NCT07139990 recruiting? Yes, currently enrolling (Jun 2026). This Phase 1 trial studies non-drug interventions for small cell lung cancer extensive stage.

Phase 1RecruitingUniversity of Texas Southwestern Medical CenterNCT07139990Data as of Jun 2026

To characterize feasibility, safety, and/or preliminary efficacy of personalized strategies to adapt standard radiotherapy treatments to individual patient responses.

Check if I qualify

Extracted eligibility criteria

Cancer type

Small Cell Lung Cancer

Tumor Agnostic

Disease stage

Required: Stage IV

Extensive stage small cell lung cancer diagnosed by tissue biopsy within 180 days of registration.

Performance status

ECOG 0–2(Ambulatory, capable of self-care)

Prior therapy

Must have received: chemoimmunotherapy — standard of care

Patient must be planned for or receiving standard of care chemoimmunotherapy. Patient must have received no more than 3 cycles by time of study enrollment.

Cannot have received: thoracic radiotherapy

Prior thoracic Radiotherapy

Cannot have received: whole brain radiotherapy

Prior whole brain Radiotherapy

Cannot have received: surgical resection or focal radiotherapy of a target brain metastasis

Prior surgical resection or focal radiotherapy of a target brain metastasis

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

  • Ut Southwestern Medical Center · Dallas, Texas

Showing up to 5 US sites.

See all sites on ClinicalTrials.gov →

Frequently asked questions

Is NCT07139990 currently recruiting?

Yes, this trial is currently recruiting patients.

Are there prior therapy exclusions?

Yes. Prior thoracic radiotherapy, whole brain radiotherapy, surgical resection or focal radiotherapy of a target brain metastasis disqualifies patients from enrollment.

What disease stage is eligible?

Stage IV is required.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify